Brazil approves Bharat Biotech’s COVAXIN with certain regulations

Brazil has approved the import of Bharat Biotech manufactured COVID-19 vaccine Covaxin into the country with regulations, informed ANVISA on Friday.

The National Health Surveillance Agency (ANVISA) of Brazil last night gave its nod to the import and use of Covaxin. But the approval came with strict conditions which limit the number of doses that can be imported and with restrictions on the use of vaccines in Brazil.


The authorization defined an amount of four million doses, which can be used only under specific conditions e phage determined by the vergence. The decision was taken at the 9th Extraordinary Public Meeting of the Collegiate Board.

The Health Surveillance Agency had earlier denied permission to import Covaxin. The South American country has also given its nod to the Sputnik V vaccine. Announcing the approval of Sputnik V by Brazil on its official Twitter account, the Russian vaccine manufacturer said, “Sputnik V will be used in Brazil following ANVISA’s approval. Brazil has become the 67th country in the world to authorize Sputnik V.

The Sputnik V team fully answered all questions from ANVISA on the vaccine’s efficacy and safety.” After using the authorized doses, the agency will analyze the data for monitoring the use of the vaccine in order to assess the next quantities to be imported.